Summary Background and Aims This systematic review and meta‐analysis aimed to
determine whether the use of therapeutic drug monitoring (TDM) in inflammatory bowel …

Introduction The relationship between autoimmune pancreatitis (AIP) type 2 and
inflammatory bowel disease (IBD) has been established and previously described within …

Background Vedolizumab registration trials were the first to include elderly patients with
moderate‐to‐severe ulcerative colitis (UC) or Crohn's disease (CD), but few real‐life data …

Background Therapeutic drug monitoring (TDM) has the potential to improve efficacy and
diminish side effects. Measuring methotrexate‐polyglutamate (MTX‐PG) in erythrocytes …

Background Many national guidelines at the European level recommend first‐line therapy
based on the anti‐TNF‐alpha adalimumab for treatment of psoriasis and psoriatic arthritis …

The world is fighting the COVID-19 outbreak and health workers, including inflammatory
bowel diseases specialists, have been challenged to address the specific clinical issues of …

Abstract Background and Objective Whether benefits and risks of intravenous (IV) infliximab
combotherapy with immunosuppressants versus infliximab monotherapy apply to …

Background A recent phase III trial did not confirm the previous clinical and endoscopic
improvements seen in patients with Crohn's disease (CD) receiving Mongersen, an oral …

Immune-mediated inflammatory diseases (IMIDs) are chronic conditions that create a
significant disease burden on millions of patients while adding a major financial burden to …

Background and aims Risks of peri-and postoperative complications after bowel surgery in
patients with inflammatory bowel disease (IBD) receiving biologics are still discussed …